Synergism between exposure to chemical carcinogens and infection with the hepatitis B virus (HBV) has been implicated in the high incidence of hepatocellular carcinoma. In this study we report that the HBV protein HBx, inhibits cellular DNA repair capacity in a p53-independent manner. Two alternative assays were used: the host cell reactivation assay, which measures the cell's capacity to repair DNA damage in a reporter plasmid, and unscheduled DNA synthesis, which measures the overall DNA repair capacity in damaged cells. Two p53-proficient cell lines, the hepatocellular carcinoma cell line HepG2 and liver epithelial cell line CCL13, were co-transfected with the pCMV-HBx reporter plasmid and the pCMV-CAT plasmid damaged with UVC radiation. Compared with cells transfected with control plasmid, the presence of HBx resulted in~50% inhibition of the cell's capacity to reactivate CAT activity of UVC-damaged plasmid, and 25% inhibition of unscheduled DNA synthesis in cells treated with either aflatoxin B1 epoxide or UVC radiation. Using the p53-deficient cell line Saos-2, we demonstrated that expression of HBx also resulted in diminished overall cellular DNA repair of damage induced by both aflatoxin B1 epoxide and UVC radiation, using both the host cell reactivation and unscheduled DNA synthesis assays. In summary, this study provides evidence for p53-independent regulation of DNA repair by HBx.
Introduction
Genes mediating DNA repair play an important role in the maintenance of gene integrity and stability in situations of genomic stress. Activities of these genes are intimately linked to cell cycle checkpoint mechanisms, which coordinate the timing of repair processes. Genotoxicity of chemical carcinogens depends on the balance between DNA damaging events and DNA repair mechanisms. Failure to repair DNA damage can enhance genotoxicity, lead to genomic instability or trigger apoptosis.
Inherited deficiencies in specific DNA repair genes are associated with various human genetic diseases, including xeroderma pigmentosum and Cockayne syndrome (1) , and individual predisposition to familial non-polyposis colorectal cancer (2) , ovarian (3), breast (4) and lung (5) cancers. Whereas most DNA repair studies have focused on the inherited gene defects associated with human diseases, there is mounting evidence that DNA repair can be altered by acquired factors, such as viruses and chemicals, leading to enhanced susceptibility to carcinogenesis (6) . For example, the p53 tumor suppressor gene, which plays a role in several mechanisms including the regulation of cell cycle checkpoint mechanisms required for DNA repair (7) , can be inactivated by many viruses as well as chemical carcinogens. The large T antigen of SV40, the E1B 55 kDa protein of adenovirus, the E6 protein of human papilloma virus (HPV) and the hepatitis B virus-x protein (HBx) (8) (9) (10) (11) (12) inactivate p53. The liver carcinogen aflatoxin B1 induces a G→T transversion in codon 249 of the p53 gene (13) , whereas benzo[a]pyrene induces transversions and substitutions in the p53 gene (14) . The most characterized model in which a synergistic association between viral infection and chemical carcinogens seems to play an important role in cancer development is hepatocellular carcinoma (HCC). HCC has a high incidence in specific geographic areas such as southern China and central Africa (15) . The concomitant exposure to liver carcinogens such as aflatoxins and HBV has been associated with a high incidence of HCC in endemic regions (16) , and in laboratory animal models (17, 18) . One of the most documented mechanisms by which HBV contributes to HCC involves the hepatitis B-x protein (HBx) (15, 19) . HBx has been shown to associate with the tumor suppressor gene product p53 and inhibits its function (10, 12, 20) . Considering the evidence that p53 interacts with several nucleotide excision repair (NER) proteins, including RPA, XPB (ERCC3) and XPD (ERCC2) (7, 10, 11, 21) , and it is involved in cell cycle regulation; its inactivation by HBx may lead to altered DNA repair, cell cycle checkpoint and/or apoptotic mechanisms. HBx itself was previously described to interfere with these cellular processes (22) (23) (24) (25) (26) (27) .
In this study we have shown that expression of HBx, in both p53-proficient and -deficient cells, inhibits DNA repair following DNA damage induced by aflatoxin B1 epoxide or UV radiation.
Materials and methods

Plasmid constructs
The HBx protein expression vector pCMV-HBx consists of the HBx gene ligated into the HindIII site of the pRc-CMV vector (Invitrogen, La Jolla, CA) (28) . The pRc-CMV plasmid was used as a negative control. The pCMV-CAT chloramphenicol reporter construct used for the host cell reactivation assay was obtained by subcloning the CAT gene into the HindII and EcoRI sites of the pRc-CMV plasmid. The pCMV-CAT reporter plasmid (50 µg/ml), which was irradiated with 1000 J/m 2 from a UVC lamp at 1 J/s/m 2 , was used in the host cell reactivation assay.
Cell lines
HepG2 is a hepatoblastoma cell line expressing wild-type p53, as determined by DNA sequence analysis using Sequenase version 2.0 (United States Biochemical, Cleveland, OH). HepG2 cells were grown in α-minimum essential medium (α-MEM; Mediatech, Washington, DC) supplemented with 10% fetal bovine serum (FBS) and gentamicin (50 µg/ml; Mediatech). CCL13 (also known as Chang cells) is a human liver epithelial cell line expressing wild-type p53, as determined by immunoprecipitation coupled western blot analysis using an antibody that only recognized wild-type p53 (Ab5; Oncogene Laboratories, Cambridge, MA). These cells were maintained in D-MEM (Mediatech), 10% FBS, and 50 µg/ml of gentamicin. Saos-2 is a human osteosarcoma cell line that lacks endogenous p53. These cells were grown in McCoy's 5A medium (Mediatech) supplemented with 15% FBS and penicillinstreptomycin (Mediatech) (50 U/ml and 50 µg/ml, respectively). All cells were maintained at 37°C in an atmosphere of 5% CO 2 . The three cell lines were obtained from the American Tissue Culture Collection (ATCC, Rockville, MD). Western blot analysis Cells were washed twice in cold phosphate-buffered saline (PBS) and then lysed directly using lysis buffer (1% Triton X-100, 10 mM Tris-HCl, pH 8.0, 60 mM KCl, 1 mM EDTA, 1 mM DTT, 0.5% NP-40, 0.5 mM phenylmethylsulfonylfluoride, 0.01 µg/ml leupeptin, 0.01 µg/ml pepstatin, 0.01 µg/ml aprotonin, 5 mM sodium orthovanadate and 10 mM sodium PPi). Total cell extracts from cells transfected with pCMV-HBx and pRc-CMV were used to examine the expression of HBx by western blot analysis. Polyacrylamide gel electrophoresis was performed using a 4% polyacrylamide stacking gel layered over a 12% resolving gel for HBx. Aliquots of 20 µg of protein extract were run at 50 V for 16 h and transferred onto nitrocellulose membrane (Costar, Cambridge, MA). The membranes were blocked overnight at 4°C with 10% low fat milk in PBS and incubated overnight with the corresponding antibody. HBx protein was detected using the monoclonal antibody 16F1 (28) and an enhanced-chemiluminescence (ECL) reagent kit (Amersham, Oakville, Ontario).
Host cell reactivation assay (HCR)
Cells were seeded at 2.7-3.0 ϫ10 5 cells per well, in six-well plates, and grown overnight in the appropriate media. The following day, the cells were transiently transfected using Lipofectamine (Gibco BRL, Burlington, Ontario) with the corresponding plasmids as described in the figure legends. Lipofectamine was used at a concentration of 3 µg/1 µg DNA. Salmon sperm DNA was added to equalize the amount of DNA transfected in each well when necessary. Cells were incubated with DNA-Lipofectamine complexes for 8 h at 37°C, 5% CO 2 and harvested 12 h after transfection. Protein extracts were used to determine chloramphenicol acetyl transferase (CAT) activity essentially as described (29) . The quantification of the reaction products in the CAT assay was performed using a Bio-Rad Gelscan Phosphoimager and a Molecular Analyst (Bio-Rad, Richmond, CA) software program. The results were expressed as the percentage of chloramphenicol conversion to its acetylated metabolites. Unscheduled DNA repair synthesis Cells were seeded at a density of 5ϫ10 5 /well in six-well plates and cultured in complete medium until cells reached full confluence. Cells were then transfected with 5 µg pCMV-HBx or pRc-CMV DNA, using 15 µg Lipofectamine. Control samples were transfected with 5 µg of salmon sperm DNA per well. After 16 h incubation at 37°C, 5% CO 2 , transfection medium was removed and cells were incubated for an additional 24 h in arginine-free medium (MEM Select-Amine; Gibco BRL) containing 1% dialyzed FBS, at 37°C, 5% CO 2 . Under these conditions, cell viability was Ͼ90% as determined by Trypan Blue staining. Cells were then treated with 50 J/m 2 UV (254 nm using a 60 Hz, 0.16 A UV lamp at a distance of 19 cm), or with 100 ng/ml of aflatoxin active metabolite, aflatoxin B1 epoxide, for 2 h. Aflatoxin B1 epoxide was synthesized as previously described (30) and its structure confirmed by HPLC and mass spectrometry analysis. After each respective treatment, cells were incubated for an additional 4 h in regular medium containing 2% serum and 10 µCi/ml [ 3 H]methyl-thymidine ([ 3 H]dThd, sp. act. 20 Ci/mmol; Du Pont-NEN, Missisauga, Ontario), at 37°C, 5% CO 2 . Cells were then washed twice with PBS, chased with 0.5 mM cold thymidine for 30 min, and DNA was extracted using DNAzol reagent (Gibco BRL). Untreated cells transfected with either pRc-CMV or pCMV-HBx were used as a control to determine the background level of 
Results
To investigate the effect of HBx on DNA repair, we first confirmed the presence of HBx in the three cell lines examined in this study, HepG2, CCL13 and Saos-2. Figure 1 shows that following transient transfection of pCMV-HBx, HBx protein was specifically identified by western blot analysis. Protein extracts of cells transfected with the negative control vector demonstrate the absence of HBx.
To determine if HBx modifies the ability of the cell to repair DNA damage, we analyzed the cellular DNA repair capacity by UDS (Figures 2 and 4) , following HBx expression and treatment with the DNA-damaging agents aflatoxin B1 epoxide or UVC radiation. The assay detects [ 3 H]dThd incorporation into DNA whereas repair takes place following DNA damage. Since the three cell lines investigated do not possess the adequate enzymatic machinery (cytochrome P450s) required to activate aflatoxin B1 (data not shown), we used the aflatoxin B1 active metabolite, aflatoxin B1 epoxide. Cell viability was examined by Trypan Blue staining, after transfection and carcinogen treatments, and was Ͼ90% in cells transfected with HBx or the negative controls (pRc-CMV or salmon sperm) following 24 h incubation of transfected cells in arginine-free medium as well as 4 h after treatment with UV radiation or aflatoxin B1 epoxide. Results of UDS show that HepG2 and CCL13 cells transfected with pCMV-HBx demonstrate 17-25% inhibition of repair of DNA damage induced by aflatoxin B1 epoxide or UVC radiation (Figure 2 ). The expression of pRc-CMV, which serves as a negative control for HBx, had no significant effect on DNA repair capacity.
To confirm and further support the results obtained by UDS, we performed the HCR assay. This procedure measures the cell's capacity to repair a UV damaged reporter plasmid following the expression of the HBx protein. The pCMVHBx expression or the negative control (pRc-CMV) vector was co-transfected with the pCMV-CAT reporter plasmid or the same plasmid irradiated with UVC light (1000 J/m 2 ) into HepG2 and CCL13 cell lines. Cell extracts were harvested 12 h after transfection and CAT assays were performed ( Figure 3 ). As compared with the non-irradiated plasmid, a decreased CAT activity was observed following transfection of the UV-treated plasmid as a consequence of DNA damage. Co-transfection of the pCMV-HBx plasmid was shown to inhibit the recovery of CAT activity from the irradiated plasmid whereas no effect of HBx was observed on the non-irradiated plasmid. Cell viability Ͼ90% was observed by Trypan Blue staining at the time of collecting the cells for CAT assay in HBx transfected cells as well in the control. HBx expression decreased cellular DNA repair capacity while promoting transactivation of Ap1 and Nf-κB responsive elements (unpublished data).
To determine whether DNA repair inhibition was p53-dependent, we tested UDS on the Saos-2 cell line, which lacks endogenous p53 due to gene deletion. These cells showed the same extent of DNA repair inhibition by HBx as the p53-proficient cell lines HepG2 and CCL13 (Figure 4a ). We also subjected Saos-2 cells to the HCR assay following the same conditions used for HepG2 and CCL13. Figure 4b shows decreased CAT activity from pCMV-CAT that was Figure 3 and Materials and methods. The results obtained using the UV-treated reporter plasmid are shown and expressed as percentage of acetylation, corresponds to the means of at least three independent experiments. *Significantly different from control pRc-CMV transfected cells at P Ͻ 0.01, using Student's t-test.
UV-treated following HBx expression when compared with the negative control.
Discussion
There is mounting evidence that individual susceptibility to carcinogenesis is affected by the interaction of several factors including genetic predisposition, exposure to genotoxic agents as well as acquired factors such as infection with viruses. Earlier epidemiological studies reported a synergistic association between exposure to environmental pollutants, such as aflatoxin B1 and chronic infection with viruses such as the hepatitis B virus (HBV), in the high incidence of hepatocellular carcinoma in endemic areas where both chronic HBV infection and exposure to aflatoxins prevail (31, 32) . This was also demonstrated in cell lines and transgenic mice expressing HBV products (17, 18) .
One of the most documented mechanisms by which HBV enhances carcinogenesis involves the HBx protein. The HBx protein is expressed in chronic hepatitis, cirrhotic liver and HCC from individuals infected with HBV (15) . It is localized in both the cytoplasm and nucleus (33) , and can therefore interact with cell signal transduction pathways and transcription machinery (33) (34) (35) . HBx has been reported to transactivate a variety of cellular genes (36) (37) (38) (39) . Furthermore, HBx associates with the p53 tumor suppressor protein in vitro and in vivo (10, 12, 15) , leading to p53 inhibition of its functions. Moreover, p53 inactivation by HBx has been implicated in liver carcinogenesis (12, 20) .
The p53 protein has been implicated in several functions including the regulation of DNA repair and the associated cell cycle checkpoint mechanisms (40) . p53 associates with XPB, XPD and p62 subunits of the TFIIH complex, which is involved in both nucleotide excision repair and transcription coupled repair mechanisms (7, 25) . The p53 protein also interacts with RPA, human Rad51 and BRCA1, which has been implicated in DNA repair (21, 41, 42) . A recent study demonstrates that p53 is phosphorylated in vitro by the TFIIHassociated kinase (CDK7-cyclin H-p36 trimeric complex) enhancing its ability to bind sequence-specific p53-responsive elements (43) . All of these interactions support a pivotal role of p53 in many cellular functions such as DNA repair, cell cycle checkpoint controls and/or apoptosis.
DNA repair is an important mechanism by which cells cope with DNA damage. In this study we examined repair of DNA damage induced by two carcinogens that trigger the nucleotide excision repair (NER) pathway: aflatoxin B1 and UVC light. UVC radiation induces pyrimidine dimers. Aflatoxin B1 is metabolized to aflatoxin-8,9-epoxide, the ultimate genotoxic metabolite that binds to DNA, predominantly at guanine residues, to form the trans-8,9-dihydro-(N 7 -guanyl)-9-hydroxyaflatoxin B1 adduct (30) . The incidence of carcinogen-induced mutations is dependent on the balance between the level of DNA damage and DNA repair capacity. Our results indicate that HBx expression was associated with inhibition of the overall DNA repair capacity in p53-proficient cells, which is in agreement with a previous study (22) . Furthermore, we have found the same extent of DNA repair inhibition in the p53-deficient cell line Saos-2, which supports the idea that HBx affects the regulation of DNA repair through a p53-independent pathway. Transactivation of multiple cellular genes, another mechanism where HBx is involved, was also reported to be independent of the p53-inhibiting functions by HBx (44) . The evidence supporting a role for p53 in DNA repair include: (i) the association of p53 with several DNA repair proteins (7, 21, 41, 42) ; (ii) p53 can recognize and bind to both irradiated DNA and mismatch DNA (45, 46) ; and (iii) disruption of wild-type p53 results in selective loss of global genomic nucleotide excision repair (47) . However, there are some discrepancies because it was also reported that Li-
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Fraumeni cells exhibit defective global DNA repair but are normal for transcription coupled repair; p53 -/-mouse fibroblasts display normal rates of repair; and p53 does not influence DNA repair capacity in vitro (48) (49) (50) . Our study does not rule out a p53-dependent mechanism because the assays used estimate the overall DNA repair capacity but not other DNA repair mechanisms such as transcription-coupled repair. The XPB and XPD NER proteins of the TFIIH complex are also involved in transcription-coupled repair (51) , and there is evidence that p53 is involved in the regulation of this process (40) . Further studies are required to understand the biological significance of these multiple interactions in relation to DNA repair and the associated cell cycle checkpoint mechanisms.
Whereas the mechanisms by which HBx interferes with DNA repair are unknown, studies by other groups have demonstrated a direct interaction of HBx with XAP-1/UVDDB, XPB and XPD proteins as well as binding of HBx to damaged DNA (22, (51) (52) (53) . Although the in vivo relevance of these interactions is still not known, they may account for the impaired DNA repair activity observed in our study. In addition, HBx has been reported to inhibit cell cycle checkpoint mechanisms required for DNA repair (24) . However, differences in cell cycle checkpoints cannot fully explain our results. The DNA repair inhibition observed in the UDS assay was carried out on cells arrested at G 0 /G 1 and where DNA semiconservative synthesis was negligible, suggesting a cell cycleindependent interaction of HBx with NER pathway.
In summary, we report the first evidence that HBx-induced DNA repair inhibition occurs through a p53-independent regulatory pathway and suggests that inhibition of DNA repair mechanisms by HBV products may contribute to the observed synergistic interaction between chronic infection with HBV and exposure to liver carcinogens. Further studies are required to determine the proteins involved and the in vivo implications of these findings.
